As Bachem is the world’s leading company in developing and manufacturing peptides and oligonucleotides, we receive a lot of interest about our company news and activities.
Learn more about what is happening at Bachem, what activities we have coming up, and what events you can meet us both virtually and in-person.
All Bachem news
- All
- Ad-hoc
- Blog
- CMC development
- Commercial APIs
- Innovation
- Life at Bachem
- Manufacturing & Capabilities
- News
- Oligonucleotides
- Peptides
- Research & specialties
- Services
- Sustainability
12Nov2025
The importance of time to market for New Chemical Entities
Learn why time to market is critical for new chemical entities. Discover how strategic CDMO partners...
31Oct2025
Anne-Kathrin Stoller to become new CEO at Bachem
Bachem appoints Anne-Kathrin Stoller as new CEO effective January 1, 2026, succeeding Thomas Meier a...
23Oct2025
Bachem announces progress in Building K start-up and expansion of its site in Vista, CA
Bachem reports progress on Building K in Bubendorf and expands its Vista, CA site to boost peptide p...
08Oct2025
What is enzymatic ligation and what are the benefits?
Learn what enzymatic ligation is in practice and how it is transforming oligonucleotide manufacturin...
18Sep2025
Key challenges in AAD sourcing: GMP compliance, supply reliability & quality control
Explore the hurdles in amino acid derivative sourcing, from GMP documentation gaps to inventory shor...
05Sep2025
5 Conjugate Reactions Improving Oligonucleotide Delivery
Learn how 5 popular conjugation reactions are being used to improve oligonucleotide delivery and ush...
20Aug2025
Bachem expands Corporate Executive Committee to include Chief Operations Officer role
The Bachem Group (SIX: BANB) announced today that Hans Van Hees, currently Chief Operations Officer ...
25Jul2025
Meet Marc Perret
Marc is a Project Manager in Operational Engineering, who contributes to designing and building a la...
24Jul2025
Bachem shows strong growth in the first half of 2025
Bachem shows strong growth in the first half of 2025. Group sales showed strong growth reaching CHF ...
24Jun2025
FMEA: A process for risk assessment in the pharmaceutical industry
Learn how FMEA enhances risk management in pharmaceutical manufacturing, ensuring product quality, p...
03Jun2025
Bachem mourns the loss of company founder Dr. h.c. Peter Grogg
The founder and honorary chairman of Bachem, Peter Grogg, passed away on Monday, June 2, 2025, at th...
12May2025
What Is Liquid Phase Peptide Synthesis?
Discover the process, benefits, and applications of liquid phase peptide synthesis, a method for cre...
30Apr2025
Bachem Annual General Meeting 2025
All proposals of the Board of Directors have been approved at Annual General Meeting 2025...
14Apr2025
Meet Paul Long
Paul Long, who leads Upstream Production at Bachem Vista, brings years of experience in growing phar...
08Apr2025
CDMOs for Clinical Trials: 5 Benefits
Partnering with a CDMO accelerates clinical trials, ensures compliance, and optimizes costs....
03Apr2025
Additional member for the Board of Directors of Bachem Holding AG
The Board of Directors will recommend the election of Dr. Simone Wyss Fedele, CEO of Switzerland Glo...
31Mar2025
CMO vs CDMO: What’s the Difference?
CMO and CDMO play distinct roles in the pharmaceutical industry. Discover the key differences and ho...
Next events coming up
Full event calendar
Interested in joining at one of our upcoming exhibitions, conferences or webinars? View our full calendar of events.